A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction

Background/Aim: Delayed wound healing is a common skin complication of diabetes, which is associated with keratinocyte injury and dysfunction. Levels of methylglyoxal (MGO), an α-dicarbonyl compound, are elevated in diabetic skin tissue and plasma, while levels of hydrogen sulfide (H2S), a critical...

Full description

Bibliographic Details
Main Authors: Chun-tao Yang, Yu Zhao, Ming Xian, Jian-hua Li, Qi Dong, Hong-bo Bai, Ji-de Xu, Mei-fen Zhang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2014-09-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/366339
_version_ 1828917023167479808
author Chun-tao Yang
Yu Zhao
Ming Xian
Jian-hua Li
Qi Dong
Hong-bo Bai
Ji-de Xu
Mei-fen Zhang
author_facet Chun-tao Yang
Yu Zhao
Ming Xian
Jian-hua Li
Qi Dong
Hong-bo Bai
Ji-de Xu
Mei-fen Zhang
author_sort Chun-tao Yang
collection DOAJ
description Background/Aim: Delayed wound healing is a common skin complication of diabetes, which is associated with keratinocyte injury and dysfunction. Levels of methylglyoxal (MGO), an α-dicarbonyl compound, are elevated in diabetic skin tissue and plasma, while levels of hydrogen sulfide (H2S), a critical gaseous signaling molecule, are reduced. Interestingly, the gas has shown dermal protection in our previous study. To date, there is no evidence demonstrating whether MGO affects keratinocyte viability and function or H2S donation abolishes these effects and improves MGO-related impairment of wound healing. The current study was conducted to examine the effects of MGO on the injury and function in human skin keratinocytes and then to evaluate the protective action of a novel H2S-releasing molecule. Methods: An N-mercapto-based H2S donor (NSHD)-1 was synthesized and its ability to release H2S was observed in cell medium and cells, respectively. HaCaT cells, a cell line of human skin keratinocyte, were exposed to MGO to establish an in vitro diabetic wound healing model. NSHD-1 was added to the cells before MGO exposure and the improvement of cell function was observed in respect of cellular viability, apoptosis, oxidative stress, mitochondrial membrane potential (MMP) and behavioral function. Results: Treatment with MGO decreased cell viability, induced cellular apoptosis, increased intracellular reactive oxygen species (ROS) content and depressed MMP in HaCaT cells. The treatment also damaged cell behavioral function, characterized by decreased cellular adhesion and migration. The synthesized H2S-releasing molecule, NSHD-1, was able to increase H2S levels in both cell medium and cells. Importantly, pretreatment with NSHD-1 inhibited MGO-induced decreases in cell viability and MMP, increases in apoptosis and ROS accumulation in HaCaT cells. The pretreatment was also able to improve adhesion and migration function. Conclusion: These results demonstrate that the novel synthesized H2S donor is able to protect human skin keratinocytes against MGO-induced injury and behavior dysfunction. We believe that more reasonable H2S-releasing molecules will bring relief to patients suffering from delayed wound healing in diabetes mellitus in the future.
first_indexed 2024-12-13T20:43:39Z
format Article
id doaj.art-7ff74d07455f46ff8d45dae8a64be4da
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-13T20:43:39Z
publishDate 2014-09-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-7ff74d07455f46ff8d45dae8a64be4da2022-12-21T23:32:05ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782014-09-013441304131710.1159/000366339366339A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and DysfunctionChun-tao YangYu ZhaoMing XianJian-hua LiQi DongHong-bo BaiJi-de XuMei-fen ZhangBackground/Aim: Delayed wound healing is a common skin complication of diabetes, which is associated with keratinocyte injury and dysfunction. Levels of methylglyoxal (MGO), an α-dicarbonyl compound, are elevated in diabetic skin tissue and plasma, while levels of hydrogen sulfide (H2S), a critical gaseous signaling molecule, are reduced. Interestingly, the gas has shown dermal protection in our previous study. To date, there is no evidence demonstrating whether MGO affects keratinocyte viability and function or H2S donation abolishes these effects and improves MGO-related impairment of wound healing. The current study was conducted to examine the effects of MGO on the injury and function in human skin keratinocytes and then to evaluate the protective action of a novel H2S-releasing molecule. Methods: An N-mercapto-based H2S donor (NSHD)-1 was synthesized and its ability to release H2S was observed in cell medium and cells, respectively. HaCaT cells, a cell line of human skin keratinocyte, were exposed to MGO to establish an in vitro diabetic wound healing model. NSHD-1 was added to the cells before MGO exposure and the improvement of cell function was observed in respect of cellular viability, apoptosis, oxidative stress, mitochondrial membrane potential (MMP) and behavioral function. Results: Treatment with MGO decreased cell viability, induced cellular apoptosis, increased intracellular reactive oxygen species (ROS) content and depressed MMP in HaCaT cells. The treatment also damaged cell behavioral function, characterized by decreased cellular adhesion and migration. The synthesized H2S-releasing molecule, NSHD-1, was able to increase H2S levels in both cell medium and cells. Importantly, pretreatment with NSHD-1 inhibited MGO-induced decreases in cell viability and MMP, increases in apoptosis and ROS accumulation in HaCaT cells. The pretreatment was also able to improve adhesion and migration function. Conclusion: These results demonstrate that the novel synthesized H2S donor is able to protect human skin keratinocytes against MGO-induced injury and behavior dysfunction. We believe that more reasonable H2S-releasing molecules will bring relief to patients suffering from delayed wound healing in diabetes mellitus in the future.http://www.karger.com/Article/FullText/366339MethylglyoxalDelayed wound healingDiabetes mellitusHydrogen sulfideKeratinocyte
spellingShingle Chun-tao Yang
Yu Zhao
Ming Xian
Jian-hua Li
Qi Dong
Hong-bo Bai
Ji-de Xu
Mei-fen Zhang
A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction
Cellular Physiology and Biochemistry
Methylglyoxal
Delayed wound healing
Diabetes mellitus
Hydrogen sulfide
Keratinocyte
title A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction
title_full A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction
title_fullStr A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction
title_full_unstemmed A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction
title_short A Novel Controllable Hydrogen Sulfide-Releasing Molecule Protects Human Skin Keratinocytes Against Methylglyoxal-Induced Injury and Dysfunction
title_sort novel controllable hydrogen sulfide releasing molecule protects human skin keratinocytes against methylglyoxal induced injury and dysfunction
topic Methylglyoxal
Delayed wound healing
Diabetes mellitus
Hydrogen sulfide
Keratinocyte
url http://www.karger.com/Article/FullText/366339
work_keys_str_mv AT chuntaoyang anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT yuzhao anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT mingxian anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT jianhuali anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT qidong anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT hongbobai anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT jidexu anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT meifenzhang anovelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT chuntaoyang novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT yuzhao novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT mingxian novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT jianhuali novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT qidong novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT hongbobai novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT jidexu novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction
AT meifenzhang novelcontrollablehydrogensulfidereleasingmoleculeprotectshumanskinkeratinocytesagainstmethylglyoxalinducedinjuryanddysfunction